Article Versions Notes

Steiner L, Bibi D, Merenlender Wagner A, Farkas P, Rudnick-Glick S, Loupe P, Hallak H. An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans. Pharmaceutics. 2025; 17(2):150. https://doi.org/10.3390/pharmaceutics17020150

Steiner, Lilach, David Bibi, Avia Merenlender Wagner, Pavel Farkas, Safra Rudnick-Glick, Pippa Loupe, and Hussein Hallak. 2025. "An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans" Pharmaceutics 17, no. 2: 150. https://doi.org/10.3390/pharmaceutics17020150

Steiner, L., Bibi, D., Merenlender Wagner, A., Farkas, P., Rudnick-Glick, S., Loupe, P., & Hallak, H. (2025). An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans. Pharmaceutics, 17(2), 150. https://doi.org/10.3390/pharmaceutics17020150